JP2008520658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520658A5 JP2008520658A5 JP2007542955A JP2007542955A JP2008520658A5 JP 2008520658 A5 JP2008520658 A5 JP 2008520658A5 JP 2007542955 A JP2007542955 A JP 2007542955A JP 2007542955 A JP2007542955 A JP 2007542955A JP 2008520658 A5 JP2008520658 A5 JP 2008520658A5
- Authority
- JP
- Japan
- Prior art keywords
- contrast agent
- amino acid
- formula
- agent according
- units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 150000003973 alkyl amines Chemical class 0.000 claims description 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004429 atoms Chemical group 0.000 claims description 2
- 125000002837 carbocyclic group Chemical group 0.000 claims description 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 239000002872 contrast media Substances 0.000 claims 11
- 125000000539 amino acid group Chemical group 0.000 claims 6
- 239000012217 radiopharmaceutical Substances 0.000 claims 4
- 230000002799 radiopharmaceutical Effects 0.000 claims 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical group OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 3
- 239000002738 chelating agent Substances 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- 229960003646 lysine Drugs 0.000 claims 2
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 claims 1
- GNTIRRQEPHPUCI-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethylamino]-2-oxoethoxy]acetic acid Chemical compound NCCOCCOCCOCCNC(=O)COCC(O)=O GNTIRRQEPHPUCI-UHFFFAOYSA-N 0.000 claims 1
- UQTZMGFTRHFAAM-ZETCQYMHSA-N 3-Iodotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(I)=C1 UQTZMGFTRHFAAM-ZETCQYMHSA-N 0.000 claims 1
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine zwitterion Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 claims 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 229940009098 Aspartate Drugs 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M CHEMBL593252 Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N DL-aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- 229940049906 Glutamate Drugs 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- NTNWOCRCBQPEKQ-YFKPBYRVSA-N N-monomethyl-arginine Chemical compound CN=C(N)NCCC[C@H](N)C(O)=O NTNWOCRCBQPEKQ-YFKPBYRVSA-N 0.000 claims 1
- 229960003104 Ornithine Drugs 0.000 claims 1
- 229960005190 Phenylalanine Drugs 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001991 dicarboxylic acids Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 230000002209 hydrophobic Effects 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000003638 reducing agent Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000003616 serine group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
Description
Claims (11)
- 以下の一般式(I)の造影剤。
Z1−L−V−Z2 (I)
式中、
Z1は式Y1Mのレポーター部分であり(ただし、Mは金属放射性核種であり、Y1はLと結合できてMを担持するキレート剤である。)、
Z2は2以上のスルホン酸基を含むシアニン色素であり、
Lは共有結合又は以下の(i)〜(v)のいずれかであり、
(i)アミノ酸残基数1〜10のペプチド、
(ii)グリシン、リシン、アスパラギン酸又はセリン残基、
(iii)1以上のジカルボン酸単位、エチレングリコール単位若しくはPEG様成分又はそれらの組合せからなるもの、
(iv)1以上のジグリコリル単位、グリコリル単位若しくはスクシニル単位又はそれらの組合せからなるもの、又は
(v)以下の式(V)の17−アミノ−5−オキソ−6−アザ−3,9,12,15−テトラオキサヘプタデカン酸の単分散PEG様構造からなるバイオモディファイヤー単位
Vは次の式(VI)の基であり、2つの環化架橋を含む。
Ra−C(=O)−X1−X2−X3−G−D−X4−X5−X6 (VI)
(式中、X1は共有結合又は1、2、3、4又は5個のアミノ酸残基であり、
X2及びX4は独立にジスルフィド結合又はチオエーテル結合を形成するシステイン又はホモシステイン残基、或いはアスパラギン酸及びリシンから選択される環化架橋を形成できるアミノ酸残基であり、
X3はアルギニン又はN−メチルアルギニンであり、
X5は疎水性アミノ酸であり、
X6はチオール含有アミノ酸残基であり、
RaはX2、X4又はX6のいずれかと架橋を形成できる−(CH2)n−又は(CH2)n−C6H4−基であり、
nは1〜10の正の整数である。) - X1が1、2、3、4又は5個のアミノ酸残基であって、1以上のアミノ酸残基が、アスパラギン酸、グルタミン酸、リシン、オルニチン、ジアミノ酪酸又はジアミノプロピオン酸から選択される、官能性側鎖を有するものである、請求項1記載の造影剤。
- X2及びX4が独立にシステイン又はホモシステイン残基である、請求項1又は請求項2記載の造影剤。
- X5がチロシン、フェニルアラニン、3−ヨードチロシン又はナフチルアラニン残基である、請求項1乃至請求項3のいずれか1項記載の造影剤。
- X6がシステイン又はホモシステイン残基である、請求項1乃至請求項4のいずれか1項記載の造影剤。
- Y1が次の式(II)のキレート剤である、請求項1乃至請求項5のいずれか1項記載の造影剤。
- 前記キレート剤が次の式(III)のものである、請求項6記載の造影剤。
- Mが99mTcである、請求項1乃至請求項7のいずれか1項記載の造影剤。
- インビボイメージングにおける画像コントラスト強調のための有効量の請求項1乃至請求項8のいずれか1項記載の一般式(I)の造影剤又はその塩を、薬学的に許容される1種以上の補助剤、賦形剤又は希釈剤と共に含んでなる放射性医薬組成物。
- 放射性医薬組成物を投与したヒト又は動物の身体の強調画像を生成させる方法に使用される放射性医薬組成物の製造に用いるための請求項1乃至請求項8のいずれか1項記載の造影剤であって、上記方法が身体の少なくとも一部分の画像を生成させることを含む、造影剤。
- 請求項1乃至請求項8のいずれか1項記載の式(I)の放射性医薬組成物の製造用キットであって、当該キットがリガンド−キレートコンジュゲート及び還元剤を含んでおり、リガンド−キレートコンジュゲートが式Y1−L−V−Z2のものであり、Y1、L、V及びZ2は請求項1で定義した通りである、キット。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20045081 | 2004-11-22 | ||
NO20045081 | 2004-11-22 | ||
PCT/NO2005/000435 WO2006054904A2 (en) | 2004-11-22 | 2005-11-21 | Contrast agents to target extracellular matrix |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012144870A Division JP2012207027A (ja) | 2004-11-22 | 2012-06-28 | 造影剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008520658A JP2008520658A (ja) | 2008-06-19 |
JP2008520658A5 true JP2008520658A5 (ja) | 2012-02-23 |
JP5116480B2 JP5116480B2 (ja) | 2013-01-09 |
Family
ID=36182407
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007542955A Expired - Fee Related JP5116480B2 (ja) | 2004-11-22 | 2005-11-21 | 造影剤 |
JP2012144870A Pending JP2012207027A (ja) | 2004-11-22 | 2012-06-28 | 造影剤 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012144870A Pending JP2012207027A (ja) | 2004-11-22 | 2012-06-28 | 造影剤 |
Country Status (17)
Country | Link |
---|---|
US (1) | US8182790B2 (ja) |
EP (2) | EP2243496A3 (ja) |
JP (2) | JP5116480B2 (ja) |
KR (1) | KR20070091609A (ja) |
CN (1) | CN101107016B (ja) |
AT (1) | ATE494913T1 (ja) |
AU (1) | AU2005307195A1 (ja) |
BR (1) | BRPI0518328A2 (ja) |
CA (1) | CA2586621A1 (ja) |
DE (1) | DE602005025911D1 (ja) |
ES (1) | ES2358745T3 (ja) |
IL (1) | IL182898A0 (ja) |
MX (1) | MX2007006050A (ja) |
NO (1) | NO20073039L (ja) |
RU (1) | RU2007118385A (ja) |
WO (1) | WO2006054904A2 (ja) |
ZA (1) | ZA200705043B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0610395D0 (en) * | 2006-05-25 | 2006-07-05 | Ge Healthcare Ltd | Novel imaging agents |
EP2056886A2 (en) * | 2006-08-28 | 2009-05-13 | GE Healthcare Limited | 68ga-labeled peptide-based radiopharmaceuticals |
JP2008266194A (ja) * | 2007-04-19 | 2008-11-06 | Hiroshi Tanaka | 分子プローブの原料として有用な新規有機化合物 |
GB0722650D0 (en) * | 2007-11-19 | 2007-12-27 | Ge Healthcare Ltd | Novel imaging method |
WO2009074628A1 (en) * | 2007-12-13 | 2009-06-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
ES2658852T3 (es) | 2008-01-18 | 2018-03-12 | Visen Medical, Inc. | Agentes de imaginología fluorescentes |
EP2300032A4 (en) | 2008-05-13 | 2012-12-05 | Univ Kansas | MARKER PRESENTING IN THE FORM OF A MAP PEPTIDE (METAL ABSTRACTION PEPTIDE) AND ASSOCIATED METHODS |
GB0814722D0 (en) * | 2008-08-12 | 2008-09-17 | Ge Healthcare Ltd | Treatment monitoring |
GB0910013D0 (en) * | 2009-06-10 | 2009-07-22 | Ge Healthcare Ltd | PET imaging of fibogenesis |
KR100991716B1 (ko) * | 2009-10-22 | 2010-11-04 | 경북대학교 산학협력단 | 광학영상 조영제, 그 용도 및 장치 |
CN102504603B (zh) * | 2011-10-20 | 2014-01-29 | 中国海洋大学 | 一种多聚物与生物染色剂的偶合物及其制备方法和用途 |
US9187735B2 (en) | 2012-06-01 | 2015-11-17 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
CN105939732A (zh) * | 2013-12-03 | 2016-09-14 | 通用医疗公司 | 分子成像探针 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
US4687659A (en) | 1984-11-13 | 1987-08-18 | Salutar, Inc. | Diamide-DTPA-paramagnetic contrast agents for MR imaging |
US6048982A (en) | 1986-04-18 | 2000-04-11 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
US5268486A (en) | 1986-04-18 | 1993-12-07 | Carnegie-Mellon Unversity | Method for labeling and detecting materials employing arylsulfonate cyanine dyes |
WO1989010758A1 (en) | 1988-05-02 | 1989-11-16 | Zynaxis Technologies, Inc. | Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
GB8903022D0 (en) | 1989-02-10 | 1989-03-30 | Celltech Ltd | Chemical compounds |
WO1993011120A1 (en) | 1991-11-27 | 1993-06-10 | Zynaxis Technologies, Incorporated | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
EP0971747B1 (en) | 1996-10-28 | 2005-12-28 | Amersham Health AS | Contrast agents |
KR20000052830A (ko) | 1996-10-28 | 2000-08-25 | 조오지 디빈센조, 토브 아스 헬지, 에바 요한손 | 진단/치료제 또는 그와 관련된 개선 |
JP2001509796A (ja) * | 1997-01-29 | 2001-07-24 | ニユコメド・イメージング・アクシエセルカペト | 重合体 |
WO1999005221A1 (en) | 1997-07-28 | 1999-02-04 | Nycomed Amersham Plc | Cyanine dyes |
US5942637A (en) | 1998-03-30 | 1999-08-24 | North Dakota State University Research Foundation | Compounds containing tetradecachlorocyclohexasilane dianion |
WO1999058139A2 (en) * | 1998-05-08 | 1999-11-18 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
US6852318B1 (en) | 1998-05-08 | 2005-02-08 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
JP2000095758A (ja) | 1998-09-18 | 2000-04-04 | Schering Ag | 近赤外蛍光造影剤および蛍光造影方法 |
US6230777B1 (en) | 1999-02-04 | 2001-05-15 | Midmac Systems, Inc. | Filter forming and joining apparatus |
DK1272507T3 (da) * | 2000-04-12 | 2005-10-03 | Amersham Health As | Integrinbindende peptidderivater |
NO20004795D0 (no) * | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
EP1337278A2 (en) * | 2000-11-27 | 2003-08-27 | Bristol-Myers Squibb Medical Imaging, Inc. | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
MXPA04000173A (es) * | 2001-07-10 | 2004-03-18 | Amersham Health As | Compuestos basados en peptidos. |
GB0206750D0 (en) | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
CA2488423A1 (en) | 2002-06-17 | 2003-12-24 | Cartela Ab | Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation |
US7063158B2 (en) | 2003-06-16 | 2006-06-20 | Deepwater Technologies, Inc. | Bottom tensioned offshore oil well production riser |
NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
GB0317815D0 (en) * | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
US7371364B2 (en) * | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
US7431914B2 (en) * | 2003-11-24 | 2008-10-07 | Ge Healthcare As | Contrast agent |
DE602005017475D1 (de) * | 2004-03-04 | 2009-12-17 | Ge Healthcare As | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie |
JP5280683B2 (ja) * | 2004-06-16 | 2013-09-04 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチド系化合物 |
JP5280682B2 (ja) * | 2004-06-16 | 2013-09-04 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチド系化合物 |
-
2005
- 2005-11-21 AT AT05817391T patent/ATE494913T1/de not_active IP Right Cessation
- 2005-11-21 JP JP2007542955A patent/JP5116480B2/ja not_active Expired - Fee Related
- 2005-11-21 AU AU2005307195A patent/AU2005307195A1/en not_active Abandoned
- 2005-11-21 CA CA002586621A patent/CA2586621A1/en not_active Abandoned
- 2005-11-21 BR BRPI0518328-6A patent/BRPI0518328A2/pt not_active Application Discontinuation
- 2005-11-21 DE DE602005025911T patent/DE602005025911D1/de active Active
- 2005-11-21 US US11/719,662 patent/US8182790B2/en not_active Expired - Fee Related
- 2005-11-21 CN CN2005800470720A patent/CN101107016B/zh not_active Expired - Fee Related
- 2005-11-21 EP EP10169506A patent/EP2243496A3/en not_active Withdrawn
- 2005-11-21 MX MX2007006050A patent/MX2007006050A/es not_active Application Discontinuation
- 2005-11-21 WO PCT/NO2005/000435 patent/WO2006054904A2/en active Application Filing
- 2005-11-21 ES ES05817391T patent/ES2358745T3/es active Active
- 2005-11-21 EP EP05817391A patent/EP1814598B1/en not_active Not-in-force
- 2005-11-21 RU RU2007118385/04A patent/RU2007118385A/ru not_active Application Discontinuation
- 2005-11-21 KR KR1020077011496A patent/KR20070091609A/ko not_active Application Discontinuation
-
2007
- 2007-05-01 IL IL182898A patent/IL182898A0/en unknown
- 2007-06-07 ZA ZA200705043A patent/ZA200705043B/xx unknown
- 2007-06-14 NO NO20073039A patent/NO20073039L/no not_active Application Discontinuation
-
2012
- 2012-06-28 JP JP2012144870A patent/JP2012207027A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008520658A5 (ja) | ||
RU2007118385A (ru) | Контрастные агенты для направлений доставки во внеклеточный матрикс | |
CN110291401B (zh) | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 | |
JP2003531835A5 (ja) | ||
AU710923B2 (en) | Radiolabeled peptides for diagnosis and therapy | |
RU2003137593A (ru) | Соединения на основе пептидов для направленной доставки к рецепторам интегринов | |
JP2008504237A5 (ja) | ||
RU2006144279A (ru) | Пептидные соединения | |
JP2020502051A5 (ja) | ||
RU2017118326A (ru) | Бициклические пептидные лиганды, специфичные для мт1-ммр | |
JP2007530441A5 (ja) | ||
HRP20161614T1 (hr) | Terapijska sredstva za smanjenje razina paratiroidnog hormona | |
JP2013155195A5 (ja) | ||
RU2007112115A (ru) | Изобретение, относящееся к glp-1 и эксендинам | |
AU2009221204A1 (en) | Bombesin analog peptide antagonist conjugates | |
JP2005518361A5 (ja) | ||
JP2012529433A5 (ja) | ||
CN1181096C (zh) | 环六肽抑生长素类似物 | |
JPH09509419A (ja) | ペプチド−キレート化剤複合体 | |
JP2954355B2 (ja) | 血栓イメージング用の放射性同位体標識化合物 | |
WO2013081091A1 (ja) | 非特異的腎集積が低減された放射性標識ポリペプチド作製用薬剤 | |
JP2008538204A (ja) | 安定化側鎖を含む放射性標識複合体キレート剤 | |
JP2007526300A5 (ja) | ||
JP2006523608A5 (ja) | ||
KR890003409A (ko) | 점막 투여시 흡수 촉진제로서의 시클릭 펩티드 |